计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| J647018-5mg |
5mg |
期货 ![]() |
| |
| J647018-10mg |
10mg |
期货 ![]() |
| |
| J647018-50mg |
50mg |
期货 ![]() |
| |
| J647018-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | ≥99% |
|---|---|
| 英文名称 | JAK3-IN-1 |
| 生化机理 | JAK3-IN-1 是一种强效、选择性和口服活性 JAK3 抑制剂,其 IC 50 为 4.8 nM。与 JAK1(IC 50 为 896 nM)和 JAK2(IC 50 为 1050 nM)相比,JAK3-IN-1 对 JAK3 的选择性高出 180 多倍。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
JAK3-IN-1 is a potent, selective and orally active JAK3 inhibitor with an IC 50 of 4.8 nM. JAK3-IN-1 shows over 180-fold more selective for JAK3 than JAK1 (IC 50 of 896 nM) and JAK2 (IC 50 of 1050 nM) In Vitro JAK3-IN-1(Compound 9; 0-5 µM; 3 hours; BMDMs cells) treatment completely inhibits IL-4 induced p-STAT6 at a concentration of 500 nM and only partially inhibits IFNβ-induced p-STAT1 at a concentration of 5.0 μM. .\nJAK3-IN-1(Compound 9) most potently inhibits JAK3 and identified fms-related tyrosine kinase 3 (FLT3) and several tyrosine protein kinase (TEC)-family kinases as being potential off-targets. Enzymatic assays using the Z’-lyte or LanthaScreen formats confirmed enzymatic inhibition of FLT3 (IC 50 = 13 nM), TTK protein kinase (TTK, IC 50 = 49 nM), BLK proto-oncogene (BLK, IC 50 = 157 nM) and tyrosine protein kinase TXK (TXK, IC 50 = 36 nM). JAK3-IN-1 shows very low inhibition scores for other JAKs and wild-type (WT) EGFR, which is consistent with the over 180-fold higher IC 50 s against EGFRWT and TYK2 (IC 50 s =409 nM, > 10000 respectively). JAK3-IN-1 possesses over 165-fold higher IC 50 s for BTK or ITK (IC 50 s = 794 and 1070 nM respectively). JAK3-IN-1(Compound 9) selectively inhibits the proliferation of JAK3-dependent Ba/F3 cells (IC 50 = 69 nM) relative to other JAK-dependent Ba/F3 cells, for which there was no antiproliferative effect at concentrations below 3.0 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: BMDMs cells Concentration: 0 µM, 0.1 µM, 0.5 µM, 1 µM, 5 µM Incubation Time: 3 hours Result: Completely inhibited IL-4 induced p-STAT6 at a concentration of 500 nM and only partially inhibited IFNβ-induced p-STAT1 at a concentration of 5.0 μM. In Vivo JAK3-IN-1(Compound 9) shows reasonable pharmacokinetic properties, with moderate T 1/2 of 1.4 h, area under the curve (AUC) value of 795 ng*hr/mL following a 10 mg/Kg oral dose and good oral bioavailability of 66%.\nAfter oral administration with JAK3-IN-1(Compound 9) (75 mpk, QD) for 8 days, the numbers of B or T lymphocytes in the tumor-bearing lungs and spleens of treated mice is not affected, however, the number of NK cells is reduced . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:JAK3 4.8 nM (IC 50 ) JAK1 896 nM (IC 50 ) JAK2 1050 nM (IC 50 ) TTK 49 nM (IC 50 ) BTK 794 nM (IC 50 ) ITK 1070 nM (IC 50 ) |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | N-[3-[[[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]methyl]phenyl]prop-2-enamide |
| INCHI | 1S/C26H30ClN7O2/c1-4-24(35)30-19-7-5-6-18(14-19)16-28-25-21(27)17-29-26(32-25)31-22-9-8-20(15-23(22)36-3)34-12-10-33(2)11-13-34/h4-9,14-15,17H,1,10-13,16H2,2-3H3,(H,30,35)(H2,28,29,31,32) |
| InChi Key | UGXCBYVBIJACEK-UHFFFAOYSA-N |
| Smiles | CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NCC4=CC(=CC=C4)NC(=O)C=C)Cl)OC |
| Isomeric SMILES | CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NCC4=CC(=CC=C4)NC(=O)C=C)Cl)OC |
| PubChem CID | 92042864 |
| 分子量 | 508.02 |
| 溶解性 | DMSO : 100 mg/mL (196.84 mM; Need ultrasonic) |
|---|---|
| 分子量 | 508.000 g/mol |
| XLogP3 | 4.200 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 507.215 Da |
| 单同位素质量Monoisotopic Mass | 507.215 Da |
| 拓扑极表面积Topological Polar Surface Area | 94.700 Ų |
| 重原子数Heavy Atom Count | 36 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 708.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |